RE:RE:10 years no increase in share price: hows that feel?floatinketucky wrote: In Jan of 2013 TLT was at .165 today ww are at .456. That is a 181.8% GAIN. There is an upward trend from 2013 Jan to present. 2018 scared the sheet out of alot of folks. But now we have a verified imporved process. Gearing up for round 2. Theralase will deliver the 1,2 punch to cancer... again. Infact out price now is back inthe uptrend range dating back to 2013.
JMO
Cheers,
We can't deny that even at 47 cents the sp is a huge disappointment for long time holders of this stock. FDA approval of the TLC-2000 alone was speculated to account for a $2 sp. You can't use a historically low sp to base its growth from. Tradionally the market has deemed a fair price between 35 cents and 45 cents. Pretty much where the sp trades these days. Which is a mystery considering the 12 month results of the 2 patients. I thought for sure when the second 12 month result was revealed the sp would climb to 75 cents and build from there but I guess the market had other ideas. One poster posted the UHN had begun screening patients for the phase 2 trial. This is June so if that's the case they won't have a good assortment of patients treated until later this summer. Assuming you need at least a sampling of 15 - 20 patients to impress the FDA that would mean that CR results wouldn't be available until the summer of 2020 at the earliest. Maybe the market sees it as no rush to jump on board.